The emerging landscape of neuroinflammatory manifestations in patients with SARS-CoV-2 infection
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
543 1
Ultima descărcare din IBN:
2021-12-06 08:35
Căutarea după subiecte
similare conform CZU
616.8-06:616-036.22:578.834 (1)
Neurologie. Neuropatologie. Sistem nervos (971)
Virologie (442)
SM ISO690:2012
CIOLAC, Dumitru, CRIVORUCICA, Igor, ZOTA, Eremei, GORINCIOI, Nadejda, EFREMOVA, Daniela, RĂCILĂ, Renata, CONDREA, Alexandra, MANEA, Diana, CRIVORUCICA, Veaceslav, GROPPA, Stanislav. The emerging landscape of neuroinflammatory manifestations in patients with SARS-CoV-2 infection. In: European Journal of Neurology, 2021, nr. S1(28), p. 471. ISSN 1351-5101.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
European Journal of Neurology
Numărul S1(28) / 2021 / ISSN 1351-5101 /ISSNe 1468-1331

The emerging landscape of neuroinflammatory manifestations in patients with SARS-CoV-2 infection

CZU: 616.8-06:616-036.22:578.834

Pag. 471-471

Ciolac Dumitru, Crivorucica Igor, Zota Eremei, Gorincioi Nadejda, Efremova Daniela, Răcilă Renata, Condrea Alexandra, Manea Diana, Crivorucica Veaceslav, Groppa Stanislav
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
 
Disponibil în IBN: 14 noiembrie 2021


Rezumat

Background and aims: Neurological complications of coronavirus disease-2019 (COVID-19) are being increasingly reported. Here, we present two cases of COVID-19 para-infectious complications involving the central nervous system, namely acute necrotizing encephalopathy (ANE) and longitudinally extensive transverse myelitis (LETM).
Methods: Patients underwent comprehensive diagnostic work-up to rule out other causes of ANE and LETM: blood and cerebrospinal fluid (CSF) inflammatory markers, PCR for SARS-CoV-2/EBV/HSV1,2,6/CMV, anti-MOG and anti-aquaporin-4 antibodies, brain and spinal cord MRI. Results: 1st case features a 44-years-old man admitted to ICU with altered mental status, bulbar palsy, and bilateral limb ataxia. The naso-/oropharyngeal swabs were positive for SARS-CoV-2 infection. CSF analysis was unremarkable, without detectable SARS-CoV-2 RNA. Brain MRI was characterized by widespread cerebellar and thalamic lesions with a hyperintense signal on FLAIR and DWI, and hemorrhages on SWI. Clinical, CSF and imaging findings were indicative of an ANE. The patient received pulse steroid therapy with a good outcome at discharge. Second case illustrates a 35-years-old breastfeeding woman with confirmed SARS-CoV-2 infection, presenting with upper and lower limb weakness, decreased sensation below the Th8 level, and urinary retention. CSF was dominated by mononuclear pleocytosis, with no traces of SARS-CoV-2 RNA. MRI scan revealed a hyperintense signal on T2 and STIR along the whole thoracic spine. These findings were suggestive of LETM, likely to COVID-19. She received pulse steroid therapy with a gradual improvement of neurological deficits.
Conclusion: Neuroinflammatory syndromes might accompany the course of COVID-19. Cytokine storm triggered by the SARS-CoV-2 infection is thought to account for the emergence of ANE and LETM. Disclosure: Nothing to disclose.